BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Thursday, May 7, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 27, 2015
View Archived Issues
Gene editing of human intestinal organoids as a model system for colorectal cancer
Read More
MRC Technology and NYU School of Medicine to develop antibody for inflammatory osteolysis
Read More
GTx licenses University of Tennessee SARD technology
Read More
Chugai Pharmaceutical reports on active first quarter of 2015
Read More
Novel PDE10 inhibitor demonstrates highly potent and selective tumor cell growth inhibitory activity
Read More
Amgen profiles progress of first quarter 2015
Read More
Lack of mitochondrial toxicity of AL-335 and AL-516
Read More
Positive European opinion on methylnaltrexone bromide for opioid-induced constipation
Read More
In vitro test first to detect psychiatric adverse events of drugs
Read More
Phase III success with single-dose dalbavancin regimen for Gram-positive skin infections
Read More
FDA accepts AbbVie's NDA for all-oral, interferon-free HCV regimen
Read More
MedImmune and Juno Therapeutics partner for immuno-oncology clinical trials
Read More
CUPID2 trial of Mydicar fails to meet endpoints
Read More
First clinical results on antibacterial OP-0595
Read More
Mitotech's antioxidant SkQ1 reduces symptoms of dry eye in phase II trial
Read More
R-Tech Ueno acquires rights to DE-105 from Santen Pharmaceutical
Read More
FDA approves Cyramza for metastatic colorectal cancer
Read More
Nissan Chemical patents new Cav3.2 inhibitors
Read More
Amgen discloses Nav1.7 inhibitors
Read More
Bayer Schering Pharma reports FXIa inhibitors
Read More
A*STAR discloses MNK1 and 2 inhibitors
Read More
Daewoong reports discovery of H+/K+-ATPase inhibitors
Read More
FDA grants orphan drug designation to GW's cannabidiol for neonatal hypoxic-ischemic encephalopathy
Read More
EMA committee recommends approval of Opdivo for advanced melanoma
Read More
European committee recommends approval of Hetlioz for non-24-hour sleep-wake disorder
Read More
